Effects of Purified Anthocyanins in People at Risk for Dementia: Study Protocol for a Phase II Randomized Controlled Trial

Background: The number of people with dementia is increasing, with huge challenges for society and health-care systems. There are no disease-modifying therapies available. There is, therefore, an urgent need to identify strategies to reduce the risk of developing dementia. Anthocyanins are a class o...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Khadija Khalifa, Anne Katrine Bergland, Hogne Soennesyn, Ketil Oppedal, Ragnhild Oesterhus, Ingvild Dalen, Alf Inge Larsen, Tormod Fladby, Helen Brooker, Keith A. Wesnes, Clive Ballard, Dag Aarsland
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2020-09-01
coleção:	Frontiers in Neurology
Assuntos:	anthocyanins mild cognitive impairment dementia randomized controlled trial intervention
Acesso em linha:	https://www.frontiersin.org/article/10.3389/fneur.2020.00916/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!